Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of CDB-2914 in Comparison to Levonorgestrel for Emergency Contraception

NCT00551616 is registered in ClinicalTrials.gov with HRA Pharma as lead sponsor.

NCT NCT00551616
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00551616 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of CDB-2914 in Comparison to Levonorgestrel for Emergency Contraception
Lead sponsor
HRA Pharma
Phase
Phase 3
Overall status
Completed
Start date
April 30, 2007
Completion date
April 30, 2009
Enrollment
2,221 (actual)
Sites
33

Conditions

As the registry lists them; a condition with its own page is linked.

contraception